Comparative adjuvant therapy to reduce vancomycin-associated nephrotoxicity in an animal model

Yongqi Xiao, Nicholas S. Teran, Cole S. Hudson, Masayuki Nigo, Vincent H. Tam · 2026

Read Comparative adjuvant therapy to reduce vancomycin-associated nephrotoxicity in an animal model by Yongqi Xiao, Nicholas S. Teran, Cole S. Hudson, Masayuki Nigo, Vincent H. Tam (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13688270.txt.

Description

Yongqi Xiao and colleagues compared kidney protection drugs in animals in 2026. Vancomycin treats serious gram-positive infections well. Kidney damage remains its major drawback. Two extra drugs were tested as helpers. Both are used for other conditions already. The model tested added therapy alongside vancomycin.

Montelukast helped only slightly in treated animals. Zileuton delayed kidney damage onset significantly. The contrast between the two was clear. Timing of damage was the key outcome. The authors back more work on zileuton. Dose and formulation studies come next. Their goal is a kidney-protective add-on therapy. Human use would need separate testing.

Catalog record

CREATORYongqi Xiao, Nicholas S. Teran, Cole S. Hudson, Masayuki Nigo, Vincent H. Tam
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE9 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13688270

Browse the full library · About the Tower of Babel